The global infertility treatment market is on a remarkable growth trajectory, with projections indicating a surge in market revenues from USD 1,899.8 million in 2024 to an impressive USD 3,843.3 million by 2034. This represents a robust compound annual growth rate (CAGR) of 7.3% over the next decade, driven by the rising demand for effective infertility solutions.
In 2023, the market achieved a revenue of USD 1,770.6 million, and the anticipated year-over-year growth rate of 7.4% for 2024 signals a continued upward trend. This acceleration is primarily attributed to societal shifts and medical advancements that have increased the need for infertility treatments globally.
Assisted Reproductive Technology (ART), particularly in vitro fertilization (IVF), remains the cornerstone of the infertility treatment market. With significant improvements in ART procedures, success rates have markedly increased, leading to greater acceptance among couples facing fertility challenges. ART’s growing prominence as a leading solution is now a fundamental pillar of the infertility treatment industry.
Infertility, which can arise from various conditions affecting either partner, requires personalized treatment approaches such as surgery, medication, and ART. As the diagnosis and treatment of infertility become more complex, the need for specialized equipment and instruments has spurred continuous innovation within the industry. The ongoing evolution of infertility treatments highlights the vital role of advanced technological solutions in improving patient outcomes.
Several key factors are driving the growth of the infertility treatment market, including shifting lifestyles, delayed marriages, and environmental factors that have contributed to the rise in infertility cases worldwide. Additionally, medical conditions such as polycystic ovary syndrome (PCOS) and other reproductive disorders are further intensifying the demand for effective and accessible treatment options.
As the infertility treatment market continues to experience robust growth, it is poised to deliver transformative solutions for individuals and couples affected by infertility. With cutting-edge medical technologies and innovative treatment advancements, the industry holds the promise of providing impactful outcomes and hope to millions of people seeking to overcome fertility challenges.
Key Takeaways: Infertility Treatment Market
- The global infertility treatment market is expected to grow significantly over the next decade, driven by factors such as increasing infertility rates and advancements in medical technology.
- The market is projected to reach USD 3,843.3 million by 2034, up from USD 1,899.8 million in 2024.
- The market is anticipated to grow at a CAGR of 7.3% during the forecast period.
- The German market holds the highest market share in Europe and is expected to grow at a CAGR of 2.3%.
- The US market is also projected to grow at a CAGR of 2.3%.
- China is the dominant player in the East Asia market and is expected to grow at a CAGR of 7.3%.
- Media & consumables are the largest segment, accounting for 46.6% of the global market.
- Assisted reproductive technology is the leading procedure, with a market share of 31.7%.
“The significant growth forecast for the infertility treatment market reflects both the increasing prevalence of infertility and the advancements in treatment technologies,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI). “As we continue to innovate and expand treatment options, we are committed to addressing the diverse needs of individuals and couples seeking to overcome infertility challenges.”
Market Value CAGR of Infertility Treatment by Country:
| Countries | Value CAGR (2024 to 2034) |
| USA | 2.30% |
| Germany | 2.30% |
| France | 3.70% |
| UK | 2.60% |
| China | 7.30% |
| India | 8.30% |
| South Korea | 5.70% |
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
Competitive Landscape:
The infertility treatment market is characterized by a high degree of fragmentation, with numerous manufacturers around the globe striving to develop innovative solutions to meet evolving customer needs.
Leading manufacturers in the infertility treatment sector are focusing on international expansion to boost revenue and extend their market reach into developing countries. This growth strategy often involves acquiring regional competitors and employing key tactics such as agreements, product launches, research sponsorships, and strategic collaborations to enhance product sales and solidify their market presence.
Notable players in the infertility treatment market include:
- Thermo Fisher Scientific Inc.: A U.S.-based multinational medical technology company, Thermo Fisher offers a range of products including Nunc™ IVF Dishes, untreated dishes, electron microscopes, lab plasticware and supplies, lab centrifuges, mass spectrometers, and next-generation sequencers.
- Cook Group Incorporated: An American medical devices company, Cook Group provides medical devices for specialties such as gastroenterology, interventional cardiology, interventional radiology, vascular surgery, and laboratory instruments.
- CooperSurgical Inc.: A global medical device manufacturer, CooperSurgical offers products like VitriFit™ Vitrification Carrier, VitriGuard™ Carrier, HBA® Assay, Standard Count Disposable Analysis Chamber, and Makler® Chamber.
Key Players of Infertility Treatment Industry:
- Thermo Fisher Scientific
- Cook Group
- CooperSurgical Inc.
- AB Scientific Ltd.
- Vitrolife
- IVFtech APS
- Hamilton Thorne Ltd.
- Esco Micro Pte Ltd.
- Genea Biomedx Ltd.
- FUJIFILM Irvine Scientific
- Baker Company INC.
Key Segments of Infertility Treatment Industry:
By Product:
In terms of product, the industry is divided into equipment (microscopes, imaging systems, sperm analyser systems, ovum aspiration pumps, micromanipulator systems, incubators, gas analyzers, laser systems, cryosystems, and sperm separation devices), media & consumables and accessories
By Procedure:
In terms of procedure, the industry is divided into assisted reproductive technology [in vitro fertilization (intracytoplasmic morphologically selected sperm injection and gamete donation), intracytoplasmic sperm injection, and surrogacy], artificial insemination (intrauterine insemination, intracervical insemination and intratubal insemination), fertility surgeries [laparoscopy, hysteroscopy, varicocelectomy, laparotomy, tubal ligation reversal, microsurgical reconstruction (vasovasostomy and vasoepididymostomy)] and other infertility treatment procedures
By Patient Type:
In terms of patient type, the industry is segregated into female infertility treatment and male infertility treatment.
By End User:
In terms of end user, the industry is segregated into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
The donor egg IVF (In-Vitro Fertilization) market size are accounted for the forecast valuation of USD 3,347.10 million in 2024. Sales of donor egg IVF (in-vitro fertilization) are proficient to attain the worth and strike USD 7,159.50 million by 2034 as these trends gain momentum and become prevalent. This portrays a robust 7.90% CAGR between 2024 and 2034.
The global in vitro fertilization banking services market demand valuation is estimated to be nearly USD 4,310.9 million in 2023. By expanding at a CAGR of 10.5% the overall size of the market is predicted to reach USD 11,652.7 million by 2033.
The global HBsAg testing market share are estimated to be worth USD 1,436.5 million in 2024 and are anticipated to reach a value of USD 2,188.5 million by 2034. Sales are projected to rise at a CAGR of 4.7% over the forecast period between 2024 and 2034.
The global patient hygiene aids market outlook are estimated to be worth USD 8,778.6 million in 2024 and are anticipated to reach a value of USD 16,020.3 million by 2034. Sales are projected to rise at a CAGR of 6.6% over the forecast period between 2024 and 2034.
The global human osteoblasts market overview are estimated to be worth USD 48.1 million in 2024 and are anticipated to reach a value of USD 85.3 million by 2034. Sales are projected to rise at a CAGR of 6.4% over the forecast period between 2024 and 2034.
The global fluid transfer solutions market forecast are estimated to be worth USD 19,203.4 million in 2024 and are anticipated to reach a value of USD 30,398.0 million by 2034. Sales are projected to rise at a CAGR of 5.5% over the forecast period between 2024 and 2034.
The global histoplasmosis treatment market analysis are estimated to be worth USD 4,670.6 million in 2024 and are anticipated to reach a value of USD 8,933.5 million by 2034. Sales are projected to rise at a CAGR of 7.1% over the forecast period between 2024 and 2034.
The global SGLT2 inhibitors treatment market growth are estimated to be worth USD 34,099.3 million in 2024 and are anticipated to reach a value of USD 83,737.4 million by 2034. Sales are projected to rise at a CAGR of 13.2% over the forecast period between 2024 and 2034.
The global long-acting monoclonal antibodies market sales are estimated to be worth USD 6,485.3 million in 2024 and are anticipated to reach a value of USD 14,528.6 million by 2034. Sales are projected to rise at a CAGR of 8.4% over the forecast period between 2024 and 2034.
The global needle-free vaccine injectors market trends are estimated to be worth USD 1,844.6 million in 2024 and are anticipated to reach a value of USD 3,091.6 million by 2034. Sales are projected to rise at a CAGR of 6.5% over the forecast period between 2024 and 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
